- Transcarent is a Series D healthcare platform based in San Francisco that provides employee health benefits solutions, leveraging generative AI to enhance health and care experiences.
- In the past year, Transcarent raised $424 million in funding and launched new features on its WayFinding platform, including voice AI scheduling and a Total Recall Memory Engine, enhancing user engagement and personalization.
- The company has appointed Dr. Alan Roga as Chief Clinical Officer to drive clinical innovation, and it has established partnerships to expand its offerings, particularly in women's health.
- Transcarent's ideal buyers are employers seeking to improve employee health outcomes and reduce costs, making it a critical solution for HR leaders focused on enhancing employee benefits and engagement.
Engineering is Transcarent’s largest department, accounting for about 19% of total headcount with 66 employees who design and maintain the company’s digital platform. Sales and Support follows with 59 employees focused on client acquisition and member assistance. Business Management and Marketing & Product each contribute 52 employees, underscoring the company’s emphasis on strategic planning and product-led growth. Healthcare roles, including clinical staff, make up 29 positions, while Finance & Administration (24), Human Resources (18), Information Technology (16), and Operations (10) round out the talent mix. A further 22 employees fall into an "Other" category covering specialized or cross-functional roles.
Transcarent’s workforce is widely distributed, with its largest concentration—nearly 200 employees—working remotely or from smaller hubs classified as "Other." Among named offices, San Francisco hosts 30 employees, reflecting the company’s Bay Area roots. Seattle (29) and Denver (24) serve as significant regional centers, complemented by teams in Chicago (19), New York (13), Los Angeles (11), Washington, D.C. (9), Boston (7), and Dallas (7). This multi-hub approach allows the company to tap talent pools across major U.S. healthcare and technology markets.
